-葡萄糖共运输体2 阻断器为介质细胞-上皮细胞转换阻断器诱导的胀
Takuya Oyakawa1, Keita Miura2, Nao Muraoka1
1Division of Cardio-oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Thoracic cancer
|December 13, 2024
概括
像empagliflozin这样的-葡萄糖共运输体2 (SGLT2) 抑制剂可以治疗由MET抑制剂引起的. 将恩帕格利弗洛辛添加到利尿剂中,在一个患有高NTproBNP水平的患者中减少了胀.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 介质细胞-上皮细胞转变因子 (MET) 抑制剂可以引起.
- 对于SGLT2抑制剂对这种特定副作用的有效性尚未得到充分证实.
研究的目的:
- 研究SGLT2抑制剂在治疗MET抑制剂诱导的瘤中的潜力.
- 报告一个使用empagliflozin治疗接受tepotinib的患者胀的病例.
主要方法:
- 分析了一个单一患者病例研究.
- 该患者接受了tepotinib用于癌症治疗,并发生了胀.
- 恩帕格利弗洛辛被添加到现有的循环利尿疗法中.
主要成果:
- 将empagliflozin添加到循环利尿剂中,导致水减少.
- 该患者的N-终端脑前性尿素 (NTproBNP) 水平升高 (≥300 pg/mL).
结论:
- 恩帕格利弗洛辛可能是一个可行的治疗选择,用于管理由MET抑制剂诱导的.
- 这一发现需要对SGLT2抑制剂进行进一步的研究,以控制药物诱导的.
相关概念视频
Secondary Active Transport
117.7K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
117.7K
Glucose Absorption Into the Small Intestine
31.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Antihypertensive Drugs: Action of Diuretics
618
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
618
Antihypertensive Drugs: Thiazide-Class Diuretics
539
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
539
Antihypertensive Drugs: Potassium-Sparing Diuretics
455
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455


